Manufacturers of laboratory tests, hospital beds and infusion pumps are among those who should alert the US Food and Drug Administration to device shortages during the COVID-19 pandemic, the agency said in a 19 June revision to a recent emergency guidance document.
The guidance instructs makers of critical products used during the ongoing public health emergency on how to let the FDA know if they’re expecting a disruption in manufacturing or...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?